Fludarabine-related pulmonary toxicity: A distinct clinical entity in chronic lymphoproliferative syndromes

Chest

Volumn 122, Issue 3, 2002, Pages 785-790

  Helman, Donald L ^a   Byrd, John C ^a,b   Ales, Noel C ^a   Shorr, Andrew F ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Chronic lymphocytic leukemia; Drug toxicity; Fludarabine

Indexed keywords

CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AGE; AGED; ARTICLE; BRONCHOSCOPY; CASE CONTROL STUDY; CHEMOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DYSPNEA; FEMALE; FEVER; GENDER; HUMAN; HYPOXEMIA; INCIDENCE; LUNG INFECTION; LUNG TOXICITY; MALE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; RISK FACTOR; THORAX RADIOGRAPHY;

EID: 0036385753     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.3.785     Document Type: Article

References (29)

1. Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N Engl J Med 2000; 343:1750-1757
2. Weiss RB, Freiman J, Kweder SL, et al. Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia. J Clin Oncol 1998; 16:1885-1889
3. Tosti S, Caruso R, D'Adamo F, et al. Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment. Ann Hematol 1992; 65:238-239
4. Di Raimondo F, Giustolisi R, Cacciola E, et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine. Leuk Lymphoma 1993; 11:63-68
5. Chun HG, Leyland-Jones BR, Caryk SM, et al. Central nervous system toxicity of fludarabine phosphate. Cancer Treat Rep 1986; 70:1225-1228
6. Sanders C, Perez EA, Lawrence HJ. Opportunistic infections in patients with chronic lymphocytic leukemia following treatment with fludarabine. Am J Hematol 1992; 39:314-315
7. Anaissie EJ, Kontoyiannis DP, O'Brien S, et al. Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Ann Intern Med 1998; 129:559-566
8. Hequet O, de Jaureguiberry JP, Jaubert D, et al. Listeriosis after fludarabine treatment for chronic lymphocytic leukemia. Hematol Cell Ther 1997; 39:89-91
9. Anaissie E, Kontoyiannis DP, Kantarjian H, et al. Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone. Ann Intern Med 1992; 117:466-469
10. Grigg A, Chapman R, Szer J. Fatal CMV pneumonia associated with steroid therapy after autologous transplantation in patients previously treated with fludarabine. Bone Marrow Transplant 1998; 21:619-621
11. Eftekhari P, Lassoued K, Oksenheudler E, et al. Severe respiratory syncytial virus pulmonary infection in a patient treated with fludarabine for chronic lymphocytic leukemia. Ann Hematol 1998; 76:225-226
12. Bastion Y, Coiffier B, Tigaud JD, et al. Pneumocystis pneumonia in a patient treated with fludarabine for chronic lymphocytic leukemia. Eur J Cancer 1991; 27:671
13. Byrd JC, Hargis JB, Kester KE, et al. Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies: a role for Pneumocystis carinii pneumonia prophylaxis. Am J Hematol 1995; 49:135-142
14. Rosenow EC, Limper AH. Drug-induced pulmonary disease. Semin Respir Infect 1995; 10:86-95
15. Hurst PG, Habib MP, Garewal H, et al. Pulmonary toxicity associated with fludarabine phosphate. Invest New Drug 1987; 5:207-210
16. Kane GC, McMichael AJ, Patrick H, et al. Pulmonary toxicity and acute respiratory failure associated with fludarabine monophosphate. Respir Med 1992; 86:261-263
17. Cervantes F, Salgado C, Montserrat E, et al. Fludarabine for prolymphocytic leukaemia and risk of interstitial pneumonitis [letter]. Lancet 1990; 336:1130
18. Levin M, Aziz M, Opitz L. Steroid-responsive interstitial pneumonitis after fludarabine therapy. Chest 1997; 111:1472-1473
19. Foss FM, Ihde DC, Linnoila IR, et al. Phase II trial of fludarabine phosphate and interferon α-2a in advanced mycosis fungoides/Sesary syndrome. J Clin Oncol 1994; 12:2051-2059
20. Grever MR. Fludarabine monophosphate in chronic lymphocytic leukemia [letter]. Blood 1986; 68:223
21. Montillo M, Tedeschi A, Centurioni R, et al. Treatment of relapsed adult acute lymphoblastic leukemia with fludarabine and cytosine arabinoside followed by granulocyte colony-stimulating factor (FLAG-GCSF). Leuk Lymphoma 1997; 25:579-582
22. Puccio CA, Mittelman A, Lichtman SM, et al. A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia. J Clin Oncol 1991; 9:1562-1569
23. Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute Sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87:4990-4997
24. Alarcon G, Kremer J, Macaluso M, et al. Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. Ann Intern Med 1997; 127:356-364
25. Malik S, Myers J, DeRemee R, et al. Lung toxicity associated with cyclophosphamide use. Am J Respir Crit Care Med 1996; 154:1851-1856
26. Mainou-Fowler T, Miller S, Proctor SJ, et al. The levels of TNF α, IL4 and IL10 production by T-cells and B-cells in chronic lymphocytic leukaemia (B-CLL). Leuk Res 2001; 25:157-163
27. Fayad L, Keating MJ, Reuben JM, et al. Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood 2001; 97:256-263
28. Mares DC, Wilkes DS. Bronchoscopy in the diagnosis of respiratory infections. Curr Opin Pulm Med 1998; 4:123-129
29. Baselski VS, Wunderink PG. Bronchoscopic diagnosis of pneumonia. Clin Microbiol Rev 1994; 70:533-558